COVID 19

Following the recommendations of the authorities for the coronavirus pandemic, SARA Pharm has taken the necessary measures to ensure the continuity of its activity. The current projects are on-going. The laboratory is operational and the necessary precautions have been taken to allow the safe reception of samples. We do not foresee any impact on our activity to date. In the event of an evolution, we will not fail to keep you informed.

Solid dosage form pre-clinical formulation development

SARA Pharm Solutions is glad to disclose its solid dosage form pre-clinical formulation service that complements the pre-formulation and solid form screening services. The solution towards a stable pre-clinical formulation is successfully made by our formulators.

We offer:

  • unique, custom made formulations for poor soluble drugs
  • screening of non-proprietary excipients
  • fully transferrable and directly applicable pre-clinical formulations